Keyphrases
Adverse Reactions
18%
Allelic Variants
26%
Antibacterial Activity
10%
Antiepileptic Drugs
11%
Antioxidant Activity
33%
Antioxidant Activity in Vitro
10%
Ayacucho
10%
Bioactive Compounds
13%
Bioequivalence
11%
Biopharmaceuticals
19%
Carbamazepine
19%
CYP2C19
12%
CYP2C9
25%
CYP2D6*3
9%
Cytochrome P450 2D6 (CYP2D6)
14%
Dissolution Media
15%
Dissolution Profile
11%
Dissolution Rate
16%
Ethanolic Extract
42%
Friability
9%
Generic Drugs
14%
Generic Formulation
14%
Glibenclamide
9%
Hydroalcoholic Extract
12%
IC50
10%
In Vitro Antioxidant Activity
29%
In Vitro Bioequivalence
16%
In Vitro Techniques
12%
Interaction Reaction
10%
Latin American
11%
Lima
16%
Mean Dissolution Time
9%
Mestizo Population
28%
Metal Ions
9%
Multi-source
10%
Patients with Epilepsy
15%
People with Epilepsy
18%
Peru
100%
Peruvian
50%
Pharmacokinetic Interaction
16%
Phenytoin
26%
Polyunsaturated Fatty Acids
16%
Quebranta
10%
Serum Concentration
10%
Similarity Factor f2
11%
Therapeutic Equivalence
10%
Total Flavonoid Content
12%
Tricontinental
11%
Valproic Acid
10%
Vitis Vinifera
25%
Pharmacology, Toxicology and Pharmaceutical Science
ABTS
7%
Adverse Event
8%
Albino Rabbit
8%
Amlodipine
8%
Anticonvulsive Agent
8%
Antimicrobial Agent
8%
Antioxidant
10%
Antioxidant Capacity
14%
Asteraceae
8%
Bioequivalence
19%
Bronchodilating Agent
8%
Carbamazepine
20%
Cavia porcellus
8%
Cyclophosphamide
8%
CYP2C19
16%
CYP2C9
8%
CYP2C9*3
5%
CYP2D6
8%
Cytochrome P450 1A1
8%
Epilepsy
8%
Escherichia coli
8%
Filamentous Fungus
5%
Flavonoid
16%
Generic Drug
5%
Glibenclamide
8%
Jatropha
8%
Lepidium
8%
Lycopersicon
8%
Metal Ion
8%
Minimum Inhibitory Concentration
8%
Oryctolagus cuniculus
8%
Pharmacogenetics
8%
Pharmacokinetic
8%
Pharmacotherapy
5%
Phenytoin
26%
Senecio
8%
Senna alata
8%
Sodium Valproate
11%
Tablet
29%
Tannin Derivative
7%
Therapeutic Equivalence
9%
